Tracking oseltamivir-resistance in New Zealand influenza viruses during a medicine reclassification in 2007, a resistant-virus importation in 2008 and the 2009 pandemic

• Main Authors: Q Sue Huang (Author), Jing Wang (Author), Wendy Gunn (Author), Molly Ziki (Author), Mackenzie Nicol (Author), Judy Bocacao (Author), Jacqui C Ralston (Author), Danielle J de Joux (Author), Matthew Peacey (Author), Richard J Hall (Author)
• Format: Book
• Published: World Health Organization Regional Office for the Western Pacific, 2012-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Oseltamivir (Tamiflu®) is an important pharmaceutical intervention against the influenza virus. The importance of surveillance for resistance to oseltamivir has been highlighted by two global events: the emergence of an oseltamivir-resistant seasonal influenza A(H1N1) virus in 2008, an...